INS and diabetes mellitus: Insulin analogue drugs have been revolutionary in the treatment of diabetes mellitus, but their high similarity to endogenous insulin can cause cross-reactivity with routine antibody-based insulin measurements [22], sometimes making it difficult to determine whether a raised level reported by an insulin assay reflects endogenous insulin secretion or an injected insulin analogue.